Compounds targeting pmp22 for the treatment of charcot-marie-tooth disease
US-2024360447-A1 · Oct 31, 2024 · US
US10370415B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10370415-B2 |
| Application number | US-201414782471-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 11, 2014 |
| Priority date | Apr 11, 2013 |
| Publication date | Aug 6, 2019 |
| Grant date | Aug 6, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are novel divalent nucleobases that each bind two nucleic acid strands, matched or mismatched when incorporated into a nucleic acid or nucleic acid analog backbone (a genetic recognition reagent, or genetic recognition reagent). In one embodiment, the genetic recognition reagent is a peptide nucleic acid (PNA) or gamma PNA (?PNA) oligomer. Uses of the divalent nucleobases and monomers and genetic recognition reagents containing the divalent nucleobases also are provided.
Opening claim text (preview).
We claim: 1. A genetic recognition reagent comprising a plurality of nucleobase residues attached to a nucleic acid or nucleic acid analog backbone, in which at least one nucleobase residue is a divalent nucleobase chosen from the following: in which each instance of R 1 is, independently, a protecting group or H and X is CH or N. 2. The genetic recognition reagent of claim 1 , in which each instance of R 1 is, independently, H or a protecting group chosen from: methyl, formyl, ethyl, acetyl, anisyl, benzyl, benzoyl, carbamate, trifluoroacetyl, diphenylmethyl, triphenylmethyl, N-hydroxysuccinimide, benzyloxymethyl, benzyloxycarbonyl, 2-nitrobenzoyl, t-Boc (tert-butyloxycarbonyl), 4-methylbenzyl, 4-nitrophenyl, 2-chlorobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2,4,5-trichlorophenyl, thioanizyl, thiocresyl, cbz (carbobenzyloxy), p-methoxybenzyl carbonyl, 9-fluorenylmethyloxycarbonyl, pentafluorophenyl, p-methoxybenzyl, 3,4-dimethozybenzyl, p-methoxyphenyl, 4-toluenesulfonyl, p-nitrobenzenesulfonates, 9-fluorenylmethyloxycarbonyl, 2-nitrophenylsulfenyl, 2,2,5,7,8-pentamethyl-chroman-6-sulfonyl, and p-bromobenzenesulfonyl. 3. The genetic recognition reagent of claim 1 , in which the backbone is chosen from one of a DNA, RNA, peptide nucleic acid (PNA), phosphorothioate, locked nucleic acid, unlocked nucleic acid, 2′-O-methyl-substituted RNA, morpholino nucleic acid, threose nucleic acid, or glycol nucleic acid backbone, or any combination thereof. 4. The genetic recognition reagent of claim 1 , in which the backbone is a peptide nucleic acid (PNA) backbone. 5. The genetic recognition reagent of claim 1 , in which the backbone is a gamma peptide nucleic acid (γPNA) backbone. 6. The genetic recognition reagent of claim 5 , in which the backbone is PEGylated, with one or more PEG moieties of two to fifty (—O—CH 2 —CH 2 —) residues. 7. The genetic recognition reagent of claim 1 , in which the backbone is a γPNA backbone in which a backbone monomer residue of the γPNA backbone is wherein R is a nucleobase residue, R 1 of the backbone monomer residue, R 2 and R 3 are, independently, H, amino acid side chains, linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxyalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene, PEGylated moieties of the preceding comprising from 1 to 50 (—O—CH 2 —CH 2 —) residues, —CH 2 —(OCH 2 —CH 2 ) q OP 1 , —CH 2 —(OCH 2 —CH 2 ) q —NHP 1 , —CH 2 —(OCH 2 —CH 2 ) q —SP 1 and —CH 2 —(SCH 2 —CH 2 ) q —SP 1 , —CH 2 —(OCH 2 —CH 2 ) r —OH, —CH 2 —(OCH 2 —CH 2 ) r —NH 2 , —CH 2 —(OCH 2 —CH 2 ) r —NHC(NH)NH 2 , or —CH 2 —(OCH 2 —CH 2 ) r —S—S[CH 2 CH 2 ] s NHC(NH)NH 2 , where P 1 is selected from the group consisting of H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; q is an integer from 0 to 10, inclusive; r and s are each independently integers from 1 to 50, inclusive; where R 1 of the backbone monomer residue and R 2 are different and one of R 1 of the backbone monomer residue or R 2 is H. 8. The genetic recognition reagent of claim 7 , in which R 2 is H, R 1 of the backbone monomer residue is an amino acid side chain that is optionally PEGylated, with one or more PEG moieties of one to twelve (—O—CH 2 —CH 2 —) residues. 9. The genetic recognition reagent of claim 1 , in which the nucleobase residues are arranged in a sequence complementary to a target sequence of a nucleic acid. 10. The genetic recognition reagent of claim 1 , having from 3 to 25 nucleobase residues. 11. The genetic recognition reagent of claim 1 , having the structure: where each instance of R 4 is a backbone monomer residue and each instance of R is one of the plurality of nucleobase residues, where at least one instance of R the divalent nucleobase, E are independently end groups, and “n” is zero or a positive integer ranging from 1 to 48, wherein the plurality of nucleobase residues forms a sequence that is complementary to a target sequence of a nucleic acid. 12. The genetic recognition reagent of claim 1 , in which the divalent nucleobase is chosen from JB1, JB2, JB3, or JB4. 13. The genetic recognition reagent of claim 1 , in which all instances of R 1 are H. 14. A monomer for production of a genetic recognition reagent comprising a backbone monomer for a genetic recognition reagent covalently attached to a divalent nucleobase chosen from the following: in which each instance of R 1 is, independently, a protecting group or H and X is CH or N. 15. The monomer of claim 14 , in which the nucleobase is one of JB1, JB2, JB3 or JB4. 16. The monomer of claim 14 , in which R 1 is a protecting group. 17. The monomer of claim 16 , in which the protecting group is chosen from one or more of: methyl, formyl, ethyl, acetyl, anisyl, benzyl, benzoyl, carbamate, trifluoroacetyl, diphenylmethyl, triphenylmethyl, N-hydroxysuccinimide, benzyloxymethyl, benzyloxycarbonyl, 2-nitrobenzoyl, t-Boc (tert-butyloxycarbonyl), 4-methylbenzyl, 4-nitrophenyl, 2-chlorobenzyloxycarbonyl, 2-bromobenzyloxycarbonyl, 2,4,5-trichlorophenyl, thioanizyl, thiocresyl, cbz (carbobenzyloxy), p-methoxybenzyl carbonyl, 9-fluorenylmethyloxycarbonyl, pentafluorophenyl, p-methoxybenzyl, 3,4-dimethozybenzyl, p-methoxyphenyl, 4-toluenesulfonyl, p-nitrobenzenesulfonates, 9-fluorenylmethyloxycarbonyl, 2-nitrophenylsulfenyl, 2,2,5,7,8-pentamethyl-chroman-6- sulfonyl, and p-bromobenzenesulfonyl. 18. The monomer of claim 14 , in which the monomer is a peptide nucleic acid (PNA) monomer. 19. The monomer of claim 14 , in which the monomer is a gamma peptide nucleic acid (γPNA) backbone monomer. 20. The monomer of claim 14 , in which the backbone monomer is PEGylated, with one or more PEG moieties of two to fifty (—O—CH 2 —CH 2 —) residues. 21. The monomer of claim 14 , in which the monomer is a γPNA monomer having the structure: wherein R is a nucleobase residue, R 1 of the γPNA monomer, R 2 and R 4 are, independently, H, amino acid side chains, linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxyalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene, PEGylated moieties of the preceding comprising from 1 to 50 (—O—CH 2 —CH 2 —) residues, —CH 2 —(OCH 2 —CH 2 ) q OP 1 , —CH 2 —(OCH 2 —CH 2 ) q —NHP 1 , —CH 2 —(OCH 2 —CH 2 ) q —SP 1 and —CH 2 —(SCH 2 —CH 2 ) q —SP 1 , —CH 2 —(OCH 2 —CH 2 ) r —OH, —CH 2 —(OCH 2 —CH 2 ) r —NH 2 , —
with deoxyribosyl as saccharide radical · CPC title
Methods for determination or identification of nucleic acids involving differential detection · CPC title
as doubly bound oxygen atoms or as unsubstituted hydroxy radicals · CPC title
Ortho-condensed systems · CPC title
with a nitrogen atom directly attached in position 2 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.